(UroToday.com) During the second day of the 2020 Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) Mini Annual Scientific Meeting (ASM), two sessions examined key trials in ANZUP. The second of these focused on trials in bladder, urothelial, and penile cancers as well as renal cell carcinoma. In this session, Dr. Dickson Hayne provided an update on ongoing trials in bladder, urothelial, and penile cancer.